<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>700</id><JournalTitle>MUSCULAR DYSTROPHY - HOPEFUL FUTURE</JournalTitle><Abstract>Muscular dystrophy refers to a group of genetically determined, progressive disorders with distinctive genotype and 
phenotype. Muscular dystrophy weakens musculoskeletal system and affects locomotion.  Duchene muscular dystrophy (DMD) 
is  the  most  common  muscular  dystrophy  with  X-linked  recessive  inheritance  and  characterized  by  severe  muscle  wasting 
resulting in muscle degeneration with early confinement to wheel chair and premature death (around 20 years). The disease is 
caused  by  mutation  in  DMD  gene  present  on  short  arm  of  X  chromosome  at  Xp21which  codes  for  cytoskeleton  protein 
â€œdystrophinâ€.  DMD  is  present  since  birth,  but  manifests  between  3-5  years  of  age.  Progressive  weakness  of  proximal  limb 
muscles  (especially  leg)  and  pelvis  is  observed.  Gowerâ€™s  sign  is  positive.  Beckerâ€™s  muscular  dystrophy  (BMD)  is  clinically 
same as DMD but is less severe. The dystrophin produced is in insufficient amount or altered in size which causes instability  of 
sarcolemma. Limb girdle muscular dystrophy  may have autosomal dominant or autosomal recessive inheritance and known as 
sacroglycanopathies. Emery-Dreifuss muscular dystrophy is associated with mutations in genes at Xp28.  Congenital muscular 
dystrophy  is  associated  with  hypotonia  and  weakness  of  proximal  muscles  at  birth  or  in  fe w  months  after  birth. 
Facioscapulohumeral dystrophy witnesses near puberty. In myotonic dystrophy smooth muscles, skeletal muscles, neurological, 
endocrinal  and  ocular  involvement  is  observed.  Physiotherapy,  cycling  and  walking  to  be  encouraged  with  avoida nce  of 
immobilization. Orthopedic braces are used to improve mobility. Though muscular dystrophy is rare but morbid condition, use 
of corticosteroids and other modalities like genetic interventions and prenatal diagnosis showed some hope. Despite giving al l 
modalities of treatment patients of dystrophy ultimately meet their fate.</Abstract><Email> harminder697@gmail.com</Email><articletype>Research</articletype><volume>6</volume><issue>12</issue><year>2015</year><keyword>Duchene muscular dystrophy(DMD),Beckerâ€™s muscular dystrophy (BMD),Dystrophin</keyword><AUTHORS>Itika Singh,Harminder Singh,Devindra Kaur</AUTHORS><afflication>Postgraduates, Department of Physiology, Pt. B.D. Sharma PGIMS, Rohtak, Haryana, India,Postgraduates, Department of Physiology, Pt. B.D. Sharma PGIMS, Rohtak, Haryana, India,Gyanecologist, General Hospital, Rohtak, Haryana, India</afflication></Article></Articles>